bioXXmed AG (T5O) Stock Price & News

All values in EUR	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	-134.00	-134.00	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	8.67K	8.67K	8.50K	8.50K
Operating expense	5.98K	5.98K	36.50K	36.50K
Total operating expenses	5.98K	5.98K	36.50K	36.50K
Operating income	-6.11K	-6.11K	-36.50K	-36.50K
Other non operating income	3.72K	3.72K	1.50K	1.50K
EBT including unusual items	-54.74K	-54.74K	-37.50K	-37.50K
EBT excluding unusual items	-4.74K	-4.74K	-37.50K	-37.50K
Income tax expense	-46.00	-46.00	-	-
Effective tax rate	0.08%	0.08%	-	-
Other operating expenses	43.79K	43.79K	28.00K	28.00K
Net income	-54.70K	-54.70K	-37.50K	-37.50K
Net profit margin	40,817.16%	40,817.16%	-	-
Earnings per share	-	-	-	-
Interest and investment income	38.00	38.00	500.00	500.00
Interest expense	-2.38K	-2.38K	-3.00K	-3.00K
Net interest expenses	-2.34K	-2.34K	-2.50K	-2.50K
Depreciation and amortization charges	-46.48K	-46.48K	-	-
EBITDA	-6.09K	-6.10K	-36.49K	-36.49K
Gain or loss from assets sale	-	-	-	-

Finance